GLOBUS MEDICAL, INC. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
GLOBUS MEDICAL, INC. (GMED) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-06
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $1.89M, a 88.34% decline year-over-year.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $774.00K, a 5.61% decline year-over-year.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $936.00K, a 44.89% increase year-over-year.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was -$380.00K, a 379.41% decline year-over-year.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $17.54M, a 666.27% increase from fiscal 2024.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $2.29M, a 74.69% decline from fiscal 2023.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $9.04M, a 372.22% increase from fiscal 2022.
- GLOBUS MEDICAL, INC. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $1.92M, a 33.36% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.66M 10-Q · filed 2026-08-06 | $3.60M derived: sum of 3 quarters · filed 2026-08-06 | $3.21M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $774.00K 10-Q · filed 2026-05-07 | $1.71M derived: sum of 2 quarters · filed 2026-05-07 | $1.33M derived: sum of 3 quarters · filed 2026-05-07 | $17.49M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $936.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $556.00K derived: sum of 2 quarters · filed 2026-02-24 | $16.72M derived: sum of 3 quarters · filed 2026-08-06 | $17.54M 10-K · filed 2026-02-24 |
| 2025-09-30 | -$380.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $15.78M derived: sum of 2 quarters · filed 2026-08-06 | $16.60M 10-Q · filed 2025-11-06 | $17.25M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $16.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $16.98M 10-Q · filed 2026-08-06 | $17.63M derived: sum of 3 quarters · filed 2026-08-06 | $17.77M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $820.00K 10-Q · filed 2026-05-07 | $1.47M derived: sum of 2 quarters · filed 2026-05-07 | $1.60M derived: sum of 3 quarters · filed 2026-05-07 | $2.37M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $646.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $782.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.54M derived: sum of 3 quarters · filed 2026-02-24 | $2.29M 10-K · filed 2026-02-24 |
| 2024-09-30 | $136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $899.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.64M 10-Q · filed 2025-11-06 | $7.54M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $763.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.51M 10-Q · filed 2025-08-07 | $7.40M derived: sum of 3 quarters · filed 2026-02-24 | $8.02M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $744.00K 10-Q · filed 2025-05-08 | $6.64M derived: sum of 2 quarters · filed 2026-02-24 | $7.26M derived: sum of 3 quarters · filed 2026-02-24 | $7.89M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $5.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.52M derived: sum of 2 quarters · filed 2026-02-24 | $7.15M derived: sum of 3 quarters · filed 2026-02-24 | $9.04M 10-K · filed 2026-02-24 |
| 2023-09-30 | $619.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $1.25M derived: sum of 2 quarters · filed 2024-11-05 | $3.15M 10-Q · filed 2024-11-05 | $3.15M derived: sum of 4 quarters · filed 2025-02-20 |
| 2023-06-30 | $632.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.53M 10-Q · filed 2024-08-06 | $2.53M derived: sum of 3 quarters · filed 2025-02-20 | |
| 2023-03-31 | $1.90M 10-Q · filed 2024-05-07 | $1.90M derived: sum of 2 quarters · filed 2025-02-20 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | $1.92M 10-K · filed 2025-02-20 | ||
| 2022-09-30 | $1.92M 10-Q · filed 2023-11-07 | |||
| 2021-12-31 | $1.44M 10-K · filed 2024-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |